Summary:
- The article analyzes the global market for Induced Pluripotent Stem Cell (iPSC) kits, projecting significant growth from its current valuation to a higher revenue milestone by 2031.
- It highlights the robust Compound Annual Growth Rate (CAGR) driven by advancements in regenerative medicine, drug discovery, and the increasing utility of iPSCs in modeling human diseases.